109 related articles for article (PubMed ID: 3909466)
21. [HLA compatibility and survival of 51 chromium-labeled allogeneic thrombocytes].
Májský A; Fortýnová J; Vopatová M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(6):831-7. PubMed ID: 6176508
[TBL] [Abstract][Full Text] [Related]
22. Platelet dose consistency and its effect on the number of platelet transfusions for support of thrombocytopenia: an analysis of the SPRINT trial of platelets photochemically treated with amotosalen HCl and ultraviolet A light.
Murphy S; Snyder E; Cable R; Slichter SJ; Strauss RG; McCullough J; Lin JS; Corash L; Conlan MG;
Transfusion; 2006 Jan; 46(1):24-33. PubMed ID: 16398727
[TBL] [Abstract][Full Text] [Related]
23. Autologous platelet transfusion in patients receiving high-dose chemotherapy and circulating progenitor cell transplantation for stage II/III breast cancer.
Pedrazzoli P; Perotti C; Noris P; Da Prada GA; Zibera C; Battaglia M; Gibelli N; Preti P; Pavesi L; Torretta L; Balduini CL; Salvaneschi L; Robustelli della Cuna G
Haematologica; 1998 Aug; 83(8):718-23. PubMed ID: 9793256
[TBL] [Abstract][Full Text] [Related]
24. Autologous platelet collection and storage to support thrombocytopenia in patients undergoing high-dose chemotherapy and circulating progenitor cell transplantation for high-risk breast cancer.
Torretta L; Perotti C; Pedrazzoli P; Dornini G; Viarengo G; Livraghi A; Noris P; Da Prada GA; Balduini CL; della Cuna GR; Salvaneschi L
Vox Sang; 1998; 75(3):224-9. PubMed ID: 9852411
[TBL] [Abstract][Full Text] [Related]
25. SLE-associated thrombocytopenia in pregnancy: successful outcome with combined IgG infusion and platelet transfusion.
Li EK; Li CY; Cohen MG
Br J Clin Pract; 1993; 47(6):338-9. PubMed ID: 8117561
[TBL] [Abstract][Full Text] [Related]
26. Investigation and management of fetomaternal alloimmune thrombocytopenia.
Carmody F; Menticoglou S
Aust N Z J Obstet Gynaecol; 2001 Feb; 41(1):109. PubMed ID: 11284639
[No Abstract] [Full Text] [Related]
27. Treating thrombocytopenia with pathogen-reduced platelets.
Sandler SG
Curr Hematol Rep; 2006 Mar; 5(1):53-4. PubMed ID: 16537046
[No Abstract] [Full Text] [Related]
28. Clinical, immunologic, and technical factors affecting recovery of platelet count after platelet transfusion.
Inverardi D; Bocchio C; Rossi L; Mazzucco L; De Paoli L; Borzini P
Haematologica; 2002 Aug; 87(8):893-4. PubMed ID: 12161372
[No Abstract] [Full Text] [Related]
29. [Blood component transfusion therapy].
Takahashi K; Juji T
Nihon Naika Gakkai Zasshi; 1991 Jun; 80(6):897-901. PubMed ID: 1919204
[No Abstract] [Full Text] [Related]
30. [Platelet transfusions].
Mandelli F
Ric Clin Lab; 1976; 6 Suppl 1():73-6. PubMed ID: 802954
[No Abstract] [Full Text] [Related]
31. Transfusion strategy: use of HLA-matched platelet transfusions for alloimmunized patients.
Menitove JE; Duquesnoy RJ
Am J Med Technol; 1981 Feb; 47(2):114-20. PubMed ID: 7223758
[TBL] [Abstract][Full Text] [Related]
32. The platelet-refractory bone marrow transplant patient: prophylaxis and treatment of bleeding.
Benson K; Fields K; Hiemenz J; Zorsky P; Ballester O; Perkins J; Elfenbein G
Semin Oncol; 1993 Oct; 20(5 Suppl 6):102-9. PubMed ID: 8211211
[TBL] [Abstract][Full Text] [Related]
33. Platelet transfusion.
Machin SJ; Kelsey H; Seghatchian MJ; Warwick R; Mackie IJ
Thromb Haemost; 1995 Jul; 74(1):246-52. PubMed ID: 8578466
[No Abstract] [Full Text] [Related]
34. The current status of platelet and granulocyte transfusions.
Seidl S; Kilp M
Haematologia (Budap); 1980; 13(1-4):145-54. PubMed ID: 7019021
[TBL] [Abstract][Full Text] [Related]
35. Clinical aspects of treatment with platelet concentrates.
Lanzer G
Acta Anaesthesiol Scand Suppl; 1996; 109():141-3. PubMed ID: 8901986
[No Abstract] [Full Text] [Related]
36. Thrombocytopenia in hydropic fetuses with parvovirus B19 infection: incidence, treatment and correlation with fetal B19 viral load.
de Haan TR; van den Akker ES; Porcelijn L; Oepkes D; Kroes AC; Walther FJ
BJOG; 2008 Jan; 115(1):76-81. PubMed ID: 18053103
[TBL] [Abstract][Full Text] [Related]
37. [Survival of 51Cr homologous platelets and HLA compatibility (author's transl)].
Fortýnová J; Májský A; Vopatová M
Cas Lek Cesk; 1980 Sep; 119(38):1023-9. PubMed ID: 7471144
[No Abstract] [Full Text] [Related]
38. Platelet transfusion and alternatives to transfusion in patients with malignancy.
Vaickus L; Breitmeyer JB; Schlossman RL; Anderson KC
Stem Cells; 1995 Nov; 13(6):588-96. PubMed ID: 8590860
[TBL] [Abstract][Full Text] [Related]
39. [Platelet transfusion: products, indications, dose, threshold and efficacy].
Andreu G; Vasse J; Tardivel R; Semana G
Transfus Clin Biol; 2009 May; 16(2):118-33. PubMed ID: 19443257
[TBL] [Abstract][Full Text] [Related]
40. [Planning platelet support as an aid in a leukemia and bone marrow transplant unit].
Mazzara R; Puig L; Gelabert A; Ercilla G; Grañena A; Marín P; Carreras E; Rozman C; Castillo R
Sangre (Barc); 1985; 30(4-B):557-77. PubMed ID: 3909467
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
